Harbour Investments »

Kalaris Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $74 13 5.77

More positions owned by Harbour Investments

Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
Apple Stock (AAPL)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p 500 Etf Etf (IVV)
Capital Group Core Plus Income Etf Etf (CGCP)
State Street Spdr S&p 500 Etf Etf (SPY)
First Trust Rising Dividend Achievers Etf Etf (RDVY)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares S&p 500 Value Etf Etf (IVE)
Schwab Us Dividend Equity Etf Etf (SCHD)

View all positions for Harbour Investments

Top funds holding Kalaris Therapeutics

Samsara BioCapital
Rtw Investments
Paradigm Biocapital Advisors
Alyeska Investment Group
Siren
Ikarian Capital
Propel Bio Management
Vanguard Group
Vanguard Capital Management
Kalehua Capital Management
Goldman Sachs Group
Woodline Partners
ADAR1 Capital Management
Whi Trust
Boothbay Fund Management

View all funds holding Kalaris Therapeutics